trending Market Intelligence /marketintelligence/en/news-insights/trending/MNvTtpbNUxKN9Z6PPamreQ2 content esgSubNav
In This List

Ascletis Pharma director resigns

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Ascletis Pharma director resigns

Ascletis Pharma Inc. said Wei Fu resigned from the board as a nonexecutive director on Dec. 24 due to other business commitments.

The company said Fu has no disagreement with the board.

China's Ascletis Pharma is an investment holding company that focuses on the development and commercialization of various drugs.